Aprea Therapeutics, Inc. (APRE) research

Aprea Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$0.77
As of
SHARE THIS CARD

Share the APRE intelligence card

A branded snapshot of APRE: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion APRE intelligence card preview
Post to X
LIVE TERMINAL

See APRE live in the terminal

Track APRE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live APRE terminal, free

Active signals for APRE

FREE, NO ACCOUNT

Every signal on APRE, as it fires

You are seeing 5 of 10 signals recorded on APRE since 2026-07-21.

The five above landed across 3 days. The other 5 were recorded on 2 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in APRE (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 03836J201 · 2026Q2$85K0.00%,
CITADEL ADVISORS LLCCUSIP 03836J201 · 2026Q2$47K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, APRE

Related tickers

See more APRE signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to APREand get the insider, 13F, options, and confluence read in one view.

Open the live APRE terminal, free